Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
-2.72%
Price
06.02.26
€18.00
Summary
This prediction is currently active. With a performance of -2.72%, the SELL prediction for Hikma Pharmaceuticals by Barclays_PLC is down slightly. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | -0.552% | -0.552% |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat